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l Patients with congenital diaphragmatic hernia (CDH) 
have unilateral or bilateral hypoplaoia of the lungs including 
delayed maturation of the terminal air sacs. Because these 
lungs are highly susceptible to barotrauma and oxygen 
toxicity, even in full-term newborns, continued research into 
optimal ventilatory regimen is essential to improve survival 
rate and to prevent ongoing lung damage. Against this 
background, the effect of exogenous surfactant application is 
evaluated. In newborn rats, CDH was induced after a single 
dose of 2,4 dichloro-4’-nitrophenyl (Nitrofen) (400 mg/ kg) on 
day 10 of gestation. The newborn rats were intubated 
immediately after hysterotomy. transferred to a heated mul- 
tichambered body plethysmograph, and artificially venti- 
lated. lnspiratory peak pressures were initially set at 17 cm 
H20, with positive end-expiratory pressure at 0 cm Hz0 and 
FIOZ at 1.0. The pressure was raised in steps of 5 cm H20, from 
5 to 30 cm H20, to obtain pressure-volume diagrams at 0, 1, 
and 6 hours of artifical ventilation. These measurements 
were obtained in controls and in CDH rats with and without 
endotracheal installation of bovine surfactant (n = 4 to 10 in 
each group). Significant differences in lung volume between 
CDH and control rats were observed at all time-points. 
Surfactant application had a positive effect on lung volume, 
especially in control rats at t = 1 hour. No significant differ- 
ences were observed between the CDH groups at t = 1 or t = 
6 hours. In this animal model, the effect of atiificial ventila- 
tion as well as the beneficial short-term effect of exogenous 
surfactant application have been evaluated. A continued 
positive effect on lung volume in CDH lungs could not be 
determined. Routine administration of exogenous surfactant 
in human CDH patients is not supported by these experimen- 
tal results. 
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I N PATIENTS who have congenital diaphragmatic hernia (CDH), abnormal morphological develop- 
ment of both lungs and the intrapulmonary blood 
From the Departments of Paediatric Surgery and Paediatnk Pul- 
monology, Sophia Children’s Hospital, Rotterdam, The Netherlands, 
and the Department of Experimental Anaesthesiology, Erasmus Univer- 
sity, Rotterdam, The Netherlands. 
Presented at the 40th Annual International Congress of the British 
Association of Paediattic Surgeons, Manchester, England, July 21-23, 
1993. 
Supported by the Sophia Foundation for Scientific Research and the 
Dutch Astma Foundation. 
Address reprint requests to Professor Dr D. Tibboel, Department of 
Paediattic Surgery, Sophia Children5 Hospital, Gordelweg 160, 3038 
GE Rotterdam, The Netherlands. 
Copyright o 1994 by U! B. Saunders Company 
0022-3468/94/2906-0027$03.00/O 
820 
vessels is present. 1-s However, reports on the biochemi- 
cal maturation of the lung in CDH are scarce. 
Hisanaga et aI6 noted low 1ecithin:sphingomyelin 
ratios (0.56 and 0.57, respectively) in two infants with 
CDH. They argued that lung hypoplasia actually 
means a reduced number of type II pneumocytes and 
reduced production of surfactant. The lecithin: 
sphingomyelin ratio reflects to some extent the matu- 
ration of the fetal lung. However, the question re- 
mains: are the ratios low because of the total reduction 
in lung tissue or because the type II cell in CDH 
functions at a lower level?’ 
Hashimoto et al8 investigated the morphological 
characteristics of the type II cell in a fetal lamb model 
of CDH. Surprisingly, they found that type II cells 
were 5 to 10 times more abundant in the lungs of 
animals with a diaphragmatic defect. No ultrastruc- 
tural changes of immaturity were observed in type II 
cells. 
Glick et al9 studied lung surfactant production in 
the fetal lamb after experimental induction of CDH 
and showed (1) a marked decrease in pulmonary 
compliance, (2) a reduction of the total amount of 
phospholipid in bronchoalveolar lavage fluid, and (3) 
a reduction in the synthesis rate of phosphatidylcho- 
line by type II cells. The authors concluded that CDH 
in the fetal lamb leads to profound lung hypoplasia 
and apparent immaturity of the surfactant system. 
In neonatal rats, CDH can be induced by feeding of 
2,4 dichloro-4’-nitrophenyl ether (Nitrofen, Rohm & 
Haas Co, Philadelphia, PA) to the mothers during 
gestation, as documented previously.‘“-” In this model, 
the lungs of CDH animals showed hypoplasia and 
lower content of disaturated phosphatidylcholine per 
microgram DNA and total disaturated phosphatidyl- 
choline, as shown by Suen.]” 
The conflicting results obtained in different animal 
models has guided us to investigate the effect of 
exogenous urfactant application in relation to changes 
in lung volume after artificial ventilation in newborn 
rats with CDH. 
MATERIALS AND METHODS 
Female Sprague Dawley rats (Harlan, Zeist. The Netherlands) 
weighing 240 to 280 g were mated during 1 hour (day 0 of 
gestation). On day 10 of gestation, 100 mg of 2.4 dichloro-4’- 
nitrophenyl ether (Nitrofen), dissolved in 1 mL of olive oil. was 
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administered by gastric tube to the Nitrofen group; controls 
received 1 mL of olive oil. Food and water were supplied ad libitum 
during the entire period. Hysterotomy was performed on gesta- 
tional day 22. 
The animals born spontaneously were excluded from the experi- 
ment because the period of spontaneous breathing could not be 
determined in detail and would influence lung function param- 
eters. There were three groups of newborns: controls, animals with 
a diaphragmatic hernia, and animals without a diaphragmatic 
defect after Nitrofen administration (lo%-20% of the animals 
receiving Nitrofen). 
Before the hysterotomy, the dam was anaesthetized with NzO 
and enflurane-inhalation, and the fetuses were delivered. Immedi- 
ately after hysterotomy, the newborns were weighed and received 
pancuronium bromide (0.08 mg/kg each second hour) and pento- 
barbital (40 mg/kg each third hour) intraperitoneally, followed by 
intubation with a metal canula. The cannulas used throughout he 
experiment were made from syringe needles (internal diameter, 0.5 
mm; external diameter, 0.7 mm). 
The intubated animals were immediately transferred to a multi- 
chambered, pressure-constant body plethysmograph heated to 
38°C. This procedure lasted 1 to 2 minutes for each animal. A 
flexible tube provided an adequate connection between the trachea 
and the body-box. The maximum number of ventilated animals per 
litter was nine. 
Artificial Ventilation 
The body plethysmograph was connected to a modified ventila- 
tor (Servo 9OOB; Siemens-Elema, Solna, Sweden), as routinely 
used in the I.C.U., and as described by Lachmann et aLI This 
equipment provides pressure-generated ventilation with decelerat- 
ing flow, using excess flow through the ventilator system. 
The ventilator settings throughout the experiment were as 
follows: F102, 1.0; frequency, 4O/min; I:E ratio, 1:2; inspiratory 
peak pressure, 17cm HzO, positive end-expiratory pressure (PEEP), 
0 cm. These settings were changed only to obtain pressure-volume 
relations, ie, the pressures were raised from 7 cm HzO, in steps of 
approximately 5cm HzO, to a maximum of 30 cm H20. The other 
settings remained the same throughout the experiments. The 
pressure-volume relations were determined for each fetus with a 
specially designed Fleisch-tube14 connected to the body plethysmo- 
graph. a differential pressure transducer (EMT 34; (Siemens- 
821 
Elema) and amplifier (EMT 31). an integrator unit (EMT 41), and 
a recorder Mingograf 81; Siemens-Elema ). 
The animals were ventilated for a maximum of 6 hours. Pressure- 
volume relations were determined at 0. 1, and 6 hours. Zero hours 
applied to the animals that were intubated immediately after 
hysterotomy because they showed no signs of spontaneous breath- 
ing. 
The animals without visible heart action, pneumothorax. or 
other complications related to insufficient ventilation or technical 
problems were excluded from the study. The same holds true for 
animals without CDH after Nitrofen administration and those with 
huge diaphragmatic defects that died less than 6 hours after birth. 
After the experiments, the animals were killed by an overdose of 
pentobarbital. 
Surfactant Application 
After intubation and the start of artificial ventilation (with peak 
inspiratory pressures of 17 cm H20, PEEP of 0 cm H20, and FIO~ 
of 1.0). both control and Nitrofen animals received either a bolus of 
bovine surfactant (0.05 mL of a 25-mg/mL solution) or nothing. 
Pressure-volume diagrams were obtained as described before. at 
t = 1 and t = 6 hours. 
Calculations 
By means of the measured pressure-volume points, a pressure- 
volume curve was plotted for each animal at each time-point. The 
volume at the standardized pressures of 7. 10, 15.20.25. and 30 cm 
Hz0 was determined from these curves and recorded. For each 
group, the means of volume were calculated at standardized 
pressures. These means were compared, and statistical significance 
was determined by means of the Mann-Whitney or Student’s I test. 
RESULTS 
For each group, the values of lung volume at the 
peak pressures of 15 and 25 cm Hz0 (with standard 
deviation) as well as the number of animals at each 
time-point are shown in Table 1. Representative 
pressure-volume diagrams are shown in Figs 1 and 2. 
Table 1. Pressure/Volume Relations in Control and CDH Rats at Different Times, Wiih or Without Exogenous Surfactant 
COIltd Hernia 
Time 
No Surfactant Surfactant No Surfactant Surfactant 
(hours) 15 cm HZ0 25 cm HI0 15 cm HZ0 25 cm Hz0 15cmH20 25 cm Hz0 15 cm Hz0 25 cm Hz0 
0 Mean 24.8 81.4 - Mean 5.9 22.4 - 
SD 17.6 32.1 SD 5.5 23.6 
” 15 n 9 
Significance Significance # # 
1 Mean 109.8 160.4 108.6 216.9 Mean 34.1 95.3 26.9 83.5 
SD 34.9 41.1 59.2 61.9 SD 13.9 38.2 17.1 20.6 
n 9 12 n 6 6 
Significance cir @ @ <%I * Significance @ # &I # (11 # (<I’# 
6 Mean 141.3 165.1 146.5 190.4 Mean 41.6 87.8 44.9 85.6 
SD 50.8 63.3 45.9 61.5 SD 27.3 25.3 30.4 38.6 
n 8 10 n 6 4 
Significance @ @ @ @ Significance (a# @ # @ # @ # 
NOTE. For all values, P < 5%. 
Abbreviations: @, significant from T = 0 in the same group; *, significant from the same group without surfactant; #, significantfrom control atthe 
same time. 
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Fig 1. Reprerentativa pressure-vol- 
ume cutves at t = 0 and t = 1 in control 
rats, CDH rats without treatment, and 
CDH rats with sutfactant. 
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volume curves at t = 6 in control 
rats, CDH rats without treatment, 
and CDH rats with surfectant. 
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There are significant differences for each time-point 
between control and CDH rats, with CDH rats having 
lower lung volumes. 
The effect of superfactant application is greater in 
controls than in CDH rats. A positive effect of 
surfactant application in control rats was found at t = 
1 hour. There were no significant differences at t = 1 
or t = 6 hours between the CDH groups. 
Animal Data 
DISCUSSION 
Our study shows not only that artificial ventilation 
of neonatal rats is possible but also that the effect of 
exogenous surfactant application can be studied in 
detail. Following the classic approach of inducing 
CDH in sheep (by Harrison et al15), Hashimoto et al8 
investigated the morphological characteristics of the 
type II cell in a fetal lamb model of CDH. Surpris- 
ingly, they found that type II cells were 5 to 10 times 
more abundant in the lungs of animals having a 
diaphragmatic defect. No ultrastructural changes of 
immaturity were observed in type II cells. 
In contrast to the above-mentioned study, various 
other research groups have documented or suggested 
that in the hypoplastic lungs of CDH rats, immaturity 
of the lungs exists. **.13~16 Suen et all3 using whole-lung 
homogenates, noted significantly lower desaturated 
phosphatidylcholine (DSPC) per microgram DNA 
824 
and total DSPC in CDH rats, and Brandsma et a&l6 
using bronchoalveolar lavages of control and CDH 
rats, came to the same conclusion. Recently, Suen et 
all7 documented the positive effect of antenatal gluco- 
corticoid treatment on the DSPC content of whole- 
lung homogenates in rats with Nitrofen-induced CDH. 
The reason we were not able to demonstrate a 
continuing positive effect on lung volume in CDH rats 
might be related to the method of delivery, dosage, 
timing, or volume of surfactant application; the effect 
of introducing PEEP should be determined as well. 
Human Data 
Increasing evidence shows that the hypoplastic 
lung in CDH is developmentally retarded.‘” A lower 
lecithin-sphingomyelin (L/S) ratio in the amniotic 
fluid6 as well as morphological findings showing 
hyaline membranes in full-term infants with CDH 
emphasize the significance of a further characteriza- 
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tion of the developing terminal lung unit in these 
patients. For a patient with CDH, accurate determi- 
nation of the presence of a surfactant deficiency, 
either primary or secondary, will be of great signifi- 
cance in the selection of appropriate treatment mo- 
dalities.‘* Moreover, the high incidence of bronchopul- 
monary dysplasia in surviving patientst9 might be 
prevented by early administration of surfactant, ei- 
ther prophylactically or therapeutically, as has been 
shown for premature infants with respiratory distress 
syndrome.20 
Treatment of CDH can be individualized by using 
standard procedures such as bronchoalveolar lavages, 
as documented by Stenmark et aL21 newborns with 
persistent pulmonary hypertension, to detect surfac- 
tant deficiency. Prospective randomized trials in CDH 
patients, using exogenous urfactant as either prophy- 
laxis or rescue therapy, should be undertaken in the 
near future to test the value of this approach. 
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